Why Is The UK Losing The Big Pharma Investment
Solutions OP Clinical Trials UK by Olga Peycheva
E36
Oct 17, 2025
11:14
Episode notes
This episode covers the latest developments in the UK life science sector where some big pharma companies are pausing investment or cancelling their investment projects. The analysis touches on the international situation and country specific problems which led to these consequences.
Keywords
innovations
small pharma companies
drug development costs
UK
clinical research news
startups
pharma industry
clinical research